AR028596A1 - Nuevos derivados de fenilglicina - Google Patents
Nuevos derivados de fenilglicinaInfo
- Publication number
- AR028596A1 AR028596A1 ARP010102385A ARP010102385A AR028596A1 AR 028596 A1 AR028596 A1 AR 028596A1 AR P010102385 A ARP010102385 A AR P010102385A AR P010102385 A ARP010102385 A AR P010102385A AR 028596 A1 AR028596 A1 AR 028596A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylglycin
- new derivatives
- derivatives
- new
- Prior art date
Links
- ZGUNAGUHMKGQNY-UHFFFAOYSA-N alpha-phenylglycine Chemical class OC(=O)C(N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00110881 | 2000-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR028596A1 true AR028596A1 (es) | 2003-05-14 |
Family
ID=8168800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010102385A AR028596A1 (es) | 2000-05-23 | 2001-05-21 | Nuevos derivados de fenilglicina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6548694B2 (es) |
| EP (1) | EP1289939A1 (es) |
| JP (1) | JP3842132B2 (es) |
| KR (1) | KR100569517B1 (es) |
| CN (1) | CN1305839C (es) |
| AR (1) | AR028596A1 (es) |
| AU (2) | AU2001281774B2 (es) |
| BR (1) | BR0110998A (es) |
| CA (1) | CA2408602C (es) |
| EC (1) | ECSP024360A (es) |
| HU (1) | HUP0302073A2 (es) |
| IL (1) | IL152581A0 (es) |
| MA (1) | MA26905A1 (es) |
| MX (1) | MXPA02011466A (es) |
| NO (1) | NO20025590L (es) |
| NZ (1) | NZ522412A (es) |
| PE (1) | PE20011314A1 (es) |
| PL (1) | PL361355A1 (es) |
| RU (1) | RU2268257C2 (es) |
| UY (1) | UY26721A1 (es) |
| WO (1) | WO2001090051A1 (es) |
| YU (1) | YU83602A (es) |
| ZA (1) | ZA200208899B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL143180A0 (en) * | 1998-12-14 | 2002-04-21 | Hoffmann La Roche | Phenylglycine derivatives |
| DE10300049A1 (de) * | 2003-01-03 | 2004-07-15 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen, die Faktor VIIa inhibieren |
| US6642386B2 (en) * | 2002-02-06 | 2003-11-04 | Hoffmann-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| GB0211931D0 (en) * | 2002-05-23 | 2002-07-03 | Univ Liverpool | Methods & device utilizing adsorption of molecules at a surface or interface |
| TW200410921A (en) * | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
| WO2004072101A2 (en) | 2003-02-11 | 2004-08-26 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| EP1594845A4 (en) | 2003-02-11 | 2008-05-21 | Bristol Myers Squibb Co | BENZENE ACETAMIDE COMPOUNDS USEFUL AS SERINE PROTEASE INHIBITORS |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| US7917130B1 (en) | 2003-03-21 | 2011-03-29 | Stratosaudio, Inc. | Broadcast response method and system |
| US7776804B2 (en) * | 2005-03-16 | 2010-08-17 | The Lubrizol Corporation | Viscosity improver compositions providing improved low temperature characteristics to lubricating oil |
| US7056932B2 (en) * | 2003-12-19 | 2006-06-06 | Hoffman-La Roche Inc. | Heterocyclyl substituted 1-alkoxy acetic acid amides |
| WO2006041119A1 (ja) * | 2004-10-13 | 2006-04-20 | Eisai R & D Management Co., Ltd. | ヒドラジド誘導体 |
| WO2006045096A2 (en) * | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| ATE479676T1 (de) | 2005-01-10 | 2010-09-15 | Bristol Myers Squibb Co | Als antikoagulanzien verwendbare phenylglycinamid-derivate |
| DE602006011752D1 (de) * | 2005-06-24 | 2010-03-04 | Bristol Myers Squibb Co | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate |
| US8044242B2 (en) | 2006-03-09 | 2011-10-25 | Bristol-Myers Squibb Company | 2-(aryloxy) acetamide factor VIIa inhibitors useful as anticoagulants |
| MY146537A (en) * | 2006-03-24 | 2012-08-15 | Eisai R&D Man Co Ltd | Triazolone derivative |
| US7855194B2 (en) | 2006-03-27 | 2010-12-21 | Hoffmann-La Roche Inc. | Pyrimidine, quinazoline, pteridine and triazine derivatives |
| JP5236664B2 (ja) | 2007-02-01 | 2013-07-17 | レスバーロジックス コーポレイション | 心血管疾患を予防および治療するための化合物 |
| EP1967522A1 (en) * | 2007-03-07 | 2008-09-10 | Novo Nordisk A/S | New blood coagulation factor inhibitors |
| EP2202231A4 (en) * | 2007-09-21 | 2011-09-28 | Eisai R&D Man Co Ltd | 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE |
| WO2009079417A1 (en) | 2007-12-14 | 2009-06-25 | Stratosaudio, Inc. | Systems and methods for scheduling interactive media and events |
| NZ586440A (en) * | 2008-06-26 | 2011-07-29 | Resverlogix Corp | Methods of preparing quinazolinone derivatives |
| EP2660238B1 (en) | 2009-01-08 | 2015-05-06 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular disease |
| MX392179B (es) | 2009-03-18 | 2025-03-21 | Resverlogix Corp | Nuevos agentes anti-inflamatorios. |
| AU2010239266B2 (en) | 2009-04-22 | 2015-01-22 | Resverlogix Corp. | Novel anti-inflammatory agents |
| CN102887836B (zh) * | 2011-07-18 | 2014-03-26 | 西南大学 | L-苯甘氨酸衍生物及其应用 |
| GB201118876D0 (en) * | 2011-11-01 | 2011-12-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| PT2773354T (pt) | 2011-11-01 | 2019-07-17 | Resverlogix Corp | Formulações orais de libertação imediata para quinazolinonas substituídas |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| EP2935253B1 (en) | 2012-12-21 | 2018-08-01 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| JP6903585B2 (ja) | 2015-03-13 | 2021-07-14 | レスバーロジックス コーポレイション | 補体関連疾患の治療のための組成物および治療方法 |
| CN111072562B (zh) * | 2019-11-07 | 2021-12-07 | 中山大学 | 一种四氢异喹啉衍生物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
| DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| DK0921116T3 (da) | 1997-12-04 | 2003-10-06 | Hoffmann La Roche | N-(4-carbamimido-phenyl)-glycinamidderivater |
| KR20010082515A (ko) * | 1998-02-17 | 2001-08-30 | 우에노 도시오 | 아미디노 유도체 및 그 유도체를 유효 성분으로서함유하는 약제 |
| IL143180A0 (en) * | 1998-12-14 | 2002-04-21 | Hoffmann La Roche | Phenylglycine derivatives |
-
2001
- 2001-05-16 US US09/858,535 patent/US6548694B2/en not_active Expired - Fee Related
- 2001-05-17 PL PL36135501A patent/PL361355A1/xx not_active Application Discontinuation
- 2001-05-17 HU HU0302073A patent/HUP0302073A2/hu unknown
- 2001-05-17 AU AU2001281774A patent/AU2001281774B2/en not_active Ceased
- 2001-05-17 MX MXPA02011466A patent/MXPA02011466A/es active IP Right Grant
- 2001-05-17 CA CA002408602A patent/CA2408602C/en not_active Expired - Fee Related
- 2001-05-17 WO PCT/EP2001/005633 patent/WO2001090051A1/en not_active Ceased
- 2001-05-17 CN CNB018099297A patent/CN1305839C/zh not_active Expired - Fee Related
- 2001-05-17 JP JP2001586241A patent/JP3842132B2/ja not_active Expired - Fee Related
- 2001-05-17 KR KR1020027015798A patent/KR100569517B1/ko not_active Expired - Fee Related
- 2001-05-17 BR BR0110998-7A patent/BR0110998A/pt not_active IP Right Cessation
- 2001-05-17 RU RU2002133215/04A patent/RU2268257C2/ru active
- 2001-05-17 NZ NZ522412A patent/NZ522412A/en unknown
- 2001-05-17 PE PE2001000442A patent/PE20011314A1/es not_active Application Discontinuation
- 2001-05-17 EP EP01960221A patent/EP1289939A1/en not_active Withdrawn
- 2001-05-17 YU YU83602A patent/YU83602A/sh unknown
- 2001-05-17 IL IL15258101A patent/IL152581A0/xx unknown
- 2001-05-17 AU AU8177401A patent/AU8177401A/xx active Pending
- 2001-05-21 AR ARP010102385A patent/AR028596A1/es not_active Application Discontinuation
- 2001-05-22 UY UY26721A patent/UY26721A1/es not_active Application Discontinuation
-
2002
- 2002-11-01 ZA ZA200208899A patent/ZA200208899B/en unknown
- 2002-11-21 NO NO20025590A patent/NO20025590L/no not_active Application Discontinuation
- 2002-11-22 MA MA26921A patent/MA26905A1/fr unknown
- 2002-11-22 EC EC2002004360A patent/ECSP024360A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2408602A1 (en) | 2001-11-29 |
| YU83602A (sh) | 2006-05-25 |
| MA26905A1 (fr) | 2004-12-20 |
| JP2003534311A (ja) | 2003-11-18 |
| NO20025590D0 (no) | 2002-11-21 |
| PL361355A1 (en) | 2004-10-04 |
| CN1430599A (zh) | 2003-07-16 |
| PE20011314A1 (es) | 2002-01-04 |
| JP3842132B2 (ja) | 2006-11-08 |
| WO2001090051A1 (en) | 2001-11-29 |
| HUP0302073A2 (hu) | 2003-09-29 |
| US6548694B2 (en) | 2003-04-15 |
| MXPA02011466A (es) | 2003-04-25 |
| KR100569517B1 (ko) | 2006-04-07 |
| UY26721A1 (es) | 2001-12-28 |
| AU2001281774B2 (en) | 2005-03-10 |
| CA2408602C (en) | 2008-01-08 |
| BR0110998A (pt) | 2003-04-08 |
| KR20030007678A (ko) | 2003-01-23 |
| US20020004608A1 (en) | 2002-01-10 |
| IL152581A0 (en) | 2003-05-29 |
| ECSP024360A (es) | 2003-03-31 |
| EP1289939A1 (en) | 2003-03-12 |
| NZ522412A (en) | 2004-05-28 |
| NO20025590L (no) | 2002-11-21 |
| ZA200208899B (en) | 2004-02-19 |
| AU8177401A (en) | 2001-12-03 |
| CN1305839C (zh) | 2007-03-21 |
| RU2268257C2 (ru) | 2006-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
| PT1303521E (pt) | Derivados de tetra-hidro-heterocicloazepinil-pirimidina | |
| DK1280809T3 (da) | Antitumorecteinascidinderivater | |
| ID30187A (id) | Dongkrak jenis pantagraf | |
| ATE298332T1 (de) | Decahydro-isochinolinderivate | |
| PT1250321E (pt) | Composicao de gliburida | |
| ATE334114T1 (de) | Substituierte c-cyclohexylmethylamin-derivate | |
| FR2810318B1 (fr) | Derives de diamano-phenothiazine | |
| AR028602A1 (es) | Derivados de pirrol | |
| AR028282A1 (es) | Derivados de aminofenil pirimidona | |
| PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
| ATE282021T1 (de) | Substituierte aminomethyl-phenyl- cyclohexanderivate | |
| PT1351959E (pt) | Novos derivados de pleuromutilina | |
| AR028607A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
| PT1246791E (pt) | Derivados de aminometilfenilciclo-hexanona | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| DK1322590T3 (da) | Substituerede 5-amino-1-penten-3-ol-derivater | |
| ATE374776T1 (de) | Pyrrolotriazolopyrimidinonderivate | |
| NO20024393D0 (no) | 2-fenylpyran-4-on-derivater | |
| PT1232141E (pt) | Eteres de o-desmetil-venlafaxina | |
| FR2810531B1 (fr) | Trocart de coelio-chirurgie | |
| UA4579S (uk) | Дозиметр-радіометр гамма-бета-випромінювань | |
| DK1246793T3 (da) | Substituerede aminomethyl-phenyl-cyclohexanderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |